Urinary tract infections;Infecciones del aparato urinario

Medicina Clinica

Volumn 129, Issue 18, 2007, Pages 707-715

  Hernández Burruezo, José Juan ^a,c   Mohamed Balghata, Mohamed Omar ^a   Aliaga Martínez, Luis ^b  

^a Unidad de Enfermedades Infecciosas   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^c NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CARBAPENEM; CEFADROXIL; CEFALEXIN; CEFAZOLIN; CEFEPIME; CEFIXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; ERTAPENEM; FLUCONAZOLE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; SULFONAMIDE; TEICOPLANIN; TETRACYCLINE DERIVATIVE; TOBRAMYCIN; TROMETAMOL; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIURIA; CATHETERIZATION; CHLAMYDIA TRACHOMATIS; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CYSTITIS; DRUG EFFICACY; DYSURIA; ECHOGRAPHY; ESCHERICHIA COLI; GARDNERELLA VAGINALIS; HEALTH CARE ORGANIZATION; HOSPITAL INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TEST; MONOTHERAPY; MYCOPLASMA HOMINIS; NEISSERIA GONORRHOEAE; PATHOGENESIS; PREVALENCE; PROTEUS MIRABILIS; PYELONEPHRITIS; PYURIA; RECURRENT DISEASE; STAPHYLOCOCCUS SAPROPHYTICUS; STREPTOCOCCUS AGALACTIAE; TRICHOMONAS VAGINALIS; UREAPLASMA UREALYTICUM; URINARY TRACT INFECTION; URINE INCONTINENCE;

EID: 37149021003     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1157/13112512     Document Type: Article

References (99)

1. Gross PA, Barrett TL, Dellinger P, Krause PJ, Martone WJ, McGowan Jr JE, et al. Purpose of quality standards for infectious diseases. Clin Infect Dis. 1994;18:421.
2. Pigrau Serrallach C, Andreu Domingo A. Infecciones urinarias. En: Ausina Ruiz V, Moreno Guillén S, editores. Tratado SEIMC de enfermedades infecciosas y microbiología clínica. Madrid: Médica Panamericana; 2006. p. 1229-40.
3. th ed. Vol 1. Philadelphia: Churchill Livingstone; 2005. p. 875-905.
4. th ed. Philadelphia: Saunders; 2004. p. 1909-13.
5. Fihn SD. Acute uncomplicated urinary tract infection in women. N Engl J Med. 2003;349:259-66.
6. th ed. Vol 1. Philadelphia: Saunders; 2000. p. 613-7.
7. Barrasa Villar JI. Infección urinaria según el sexo. Med Clin (Barc). 1997;109:333-5.
8. Stamm WE. Scientific and clinical challenges in the management of urinary tract infections. Am J Med. 2002;113 Suppl 1A:1-4.
9. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economics cost. Am J Med. 2002;113 Suppl 1A:5-13.
10. Sheffield JS, Cunnigham FG. Urinary tract infection in women. Obstet Gynecol. 2005;106:1085-92.
11. Hooton TM, Scholes D, Stapleton AE, Roberts PL, Winter C, Gupta K, et al. A prospective study of asymptomatic bacteriuria in sexually active young women. N Engl J Med. 2000;343:992-7.
12. Hooton TM, Scholes D, Hughes JP, Winter C, Roberts PL, Stapleton AE, et al. A prospective study for symptomatic urinary tract infection in young women. N Engl J Med. 1996;335:468-74.
13. Krieger JN. Urinary tract infections: what's new? J Urol. 2002;168:2351-8.
14. Foster KT, Marshall L. Management of urinary tract infections. An overview of treatment considerations. US Pharm. 2004;6:60-71.
15. Scholes D, Hooton TM, Roberts PL, Gupta K, Stapleton AE, Stamm WE. Risk factors associated with acute pyelobephritis in healthy women. Ann Intern Med. 2005;142:20-7.
16. Stapleton A. Urinary tract infections in patients with diabetes. Am J Med. 2002;113 Suppl 1A:80-4.
17. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med. 1999;341:1906-12.
18. Raz R, Gennesin Y, Wasser J, Stoler Z, Rosenfeld S, Rottensterich E, et al. Recurrent urinary tract infection in postmenopausal women. Clin Infect Dis. 2000;30:152-6.
19. Hu KK, Boyko EJ, Scholes D, Normand E, Chen CL, Grafton J, et al. Risk factors for urinary tract infections in postmenopausal women. Arch Intern Med. 2004;164:989-93.
20. Sheinfeld J, Schaeffer AJ, Cordon-Cardo C, Rogatko A, Fair WR. Association of the Lewis blood-group phenotipe with recurrent urinary tract infections in women. N Engl J Med. 1989;320:733-7.
21. Lomberg H, Hanson LA, Jacobsson B, Jodal U, Leffler H, Svanborg-Edén C. Correlation of P blood group, vesicoureteral reflux and bacterial attachment in patients with recurrent pyelonephritis. N Engl J Med. 1983;308:1189-92.
22. Shortliffe LMD, McCune JD. Urinary tract infection at the age extremes: pediatrics and geriatrics. Am J Med. 2002;113 Suppl 1A:55S-66S.
23. Nicolle LE, Bradley S, Colgan R, Rice JC, Shaeffer A, Hooton TM. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005; 40:643-54 [fe de errores: Clin Infect Dis. 2005;40:1556].
24. Barnes RC, Daifuku R, Roddy RE, Stamm WE. Urinary tract infection in sexually active homosexual men. Lancet. 1986;1:171-3.
25. Spach DH, Stapleton AE, Stamm WE. Lack circumcision increases the risk of urinary in young men. JAMA. 1992;267:679-81.
26. Schonwald S, Begovac J, Skerk V. Urinary tract infections in HIV disease. Int J Antimicrob Agents. 1999;11:309-11.
27. Saint S, Wiese J, Amory JK, Bernstein ML, Patel UD, Zemencuk JK, et al. Are physicians aware of which of their patients have indwelling urinary catheters? Am J Med. 2000;109:476-80.
28. Weinstein JW, Mazon D, Pantelick E, Reagan-Cirincione P, Dembry LM, Hierholzer WJ Jr. A decade of prevalence surveys in a tertiary-care center: trends in nosocomial infection rates, device utilization, and patient acuity. Infect Control Hosp Epidemiol. 1999;20:543-8.
29. Warren JW. Catheter-associated urinary tract infections. Int J Antimicrob Agents. 2001;17:299-303.
30. Barrasa Villar JI, Vidal Peracho C, Aspíroz Sancho C. Las infecciones urinarias en los pacientes con sonda vesical no permanente (I). Factores de riesgo, patogenia, etiología y curso clínico. Med Clin (Barc). 1996;106:704-10.
31. Vaqué J, Rosselló J, Trilla A, Monge V, García-Caballero J, Arribas JL, et al. Nosocomial infections in Spain. Results of five nationwide serial prevalence surveys (EPINE Project, 1990-94). Nosocomial Infections Prevalence Study in Spain. Infect Control Hospital Epidemiol. 1996;17:293-7.
32. Saint S. Clinical and economic consequences of nosocomial catheter-related bacteriuria. Am J Infect Control. 2000;28:68-75.
33. Saint S, Lipsky B. Preventing catheter-related bacteruria: should we? can we? how? Arch Intern Med. 1999;159:800-8.
34. Medina M, Martínez-Gallego G, Sillero-Arenas M, Delgado-Rodríguez M. Risk factors and length of stay attributable to hospital infections of the urinary tract in general surgery patients. Enferm Infecc Microbiol Clin. 1997;15:310-4.
35. Bonadio M, Meini M, Spitaleri P, Gigli C. Current microbiological and clinical aspects of urinary tract infections. Eur Urol. 2001;40:439-45.
36. Hooton TM. Pathogenesis of urinary tract infections: an update. J Antimicrob Chemother. 2000;46 Suppl 1:1-7.
37. Trautner BW, Darouiche RO. Catheter-associated infections. Pathogenesis affects prevention. Arch Intern Med. 2004;164:842-50.
38. Ronald A. Etiology of urinary tract infection: traditional and emerging pathogens. Am J Med. 2002;113 Suppl 1A:15-9.
39. Stamm WE, Hooton TH. Management of urinary tract infections in adults. N Engl J Med. 1993;329:1328-34.
40. Hill JB, Sheffield JS, McIntire DD, Wendel GD. Acute pyelonephritis in pregnancy. Obstet Gynecol. 2005;105:18-23.
41. McKenna DS, Matson S, Northern I. Maternal group B streptococcal (GBS) genital tract colonization at term in women who have asymptomatic GBS bacteriuria. Infect Dis Obstet Gynecol. 2003;11:203-7.
42. Andreu A, Alós JI, Gobernado M, Marco F, De la Rosa M, García-Rodríguez JA, Grupo Cooperativo Español para el Estudio de la Sensibilidad Antimicrobiana de los Patógenos Urinarios. Etiología y sensibilidad a los antimicrobianos de los uropatógenos causantes de la infección urinaria baja adquirida en la comunidad. Estudio nacional multicéntrico. Enferm Infecc Microbiol Clin. 2005;23:4-9.
43. Rodríguez FC, Franco-Álvarez de Luna F, Gordillo RM, Ibarra A, Casal M. Microorganismos aislados de muestras de orina procedentes de la comunidad y patrón de sensibilidad en un periodo de 12 años. Rev Esp Quimioter. 2005;18:159-67.
44. Aliaga L, Mediavilla JD, Cobo F. A clinical index predicting mortality with Pseudomonas aeruginosa bacteremia. J Med Microbiol. 2002;51:615-9.
45. Aliaga L, Mediavilla JD, Llosá J, Miranda C, Rosa-Fraile M. Clinical significance of polymicrobial versus monomicrobial bacteremia involving Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis. 2000;19:871-4.
46. Siroky MB. Pathogenesis of bacteriuria and infection in the spinal cord injured patient. Am J Med. 2002;113 Suppl 1A:67-79.
47. Cisneros JM, Rodríguez-Baño J. Nococomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect. 2002;8:687-93.
48. Aliaga L, Cobo F, Jiménez A, Miranda C. Prosthetic valve endocarditis due to Mycoplasma hominis. Clin Microbiol Newsletter. 2002;24:85-6.
49. Bent S, Saint S. The optimal use of diagnostic testing in women with acute uncomplicated cystitis. Am J Med. 2002;113 Suppl 1A:20-8.
50. Ramakrishnan K, Scheid DC. Diagnosis and management of acute pyelonephritis in adults. Am Fam Physician. 2005;71:933-42 [fe de errores: Am Fam Physician. 2005;72:2180).
51. Sing I, Pachisia SS, Kumar S, Avora VC, Kumar P. Emphysematous pyelonephritis a consequence of adenocarcinoma of urinary bladder in a nondiabetic patient. J Postgrad Med. 2005;51:324-5.
52. Tambyah PA, Maki DG. Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients. Arch Intern Med. 2000;160:678-82.
53. Platt R, Polk BF, Murdock B, Rosner B. Mortality associated with nosocomial urinary-tract infection. N Engl J Med. 1982;307:637-42.
54. Leisure MK, Dudley SM, Donowitz LG. Does a clean-catch urine sample reduce bacterial contamination? N Engl J Med. 1993;328:289-90.
55. Lifshitz E, Kramer L. Outpatient urine culture. Does collection technique matter? Arch Intern Med. 2000;160:2537-40.
56. Wilson ML, Gaido L. Laboratory diagnosis of urinary tract infections in adults patients. Clin Infect Dis. 2004;38:1150-8.
57. De Cueto M. Diagnóstico microbiológico de la infección del tracto urinario. Enferm Infecc Microbiol Clin. 2005;23 Supl 4:9-14.
58. Warren JW, Abrutyn E, Hebel JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis. 1999;29:745-58.
59. Fox GN. Sensitivity and specificity of urinary nitrite for UTIs. Am Fam Physician. 2005;72:2180.
60. Richards D, Toop L, Chambers S. Response to antibiotics of women with symptoms of urinary tract infection but negative dipstick urine test results: double blind randomised controlled trial. BMJ. 2005;331:143.
61. Velasco M, Martínez JA, Moreno-Martínez A, Horcajada JP, Ruiz J, Barranco M, et al. Bood cultures for women with uncomplicated acute pyelonephritis: are they necessary? Clin Infect Dis. 2003;37:1127-30.
62. Tal S, Guller V, Levi S, Bardenstein R, Berger D, Gurevich I, et al. Profile and prognosis of febrile elderly patients with bacteremic urinary tract infection. J Infection. 2005;50:296-305.
63. Lorente JA, Placer J, Salvadó M, Segura C, Gelabert-Mas A. Evolución de la resistencia antibiótica en las infecciones urinarias adquiridas en la comunidad. Rev Clin Esp. 2005;205:259-64.
64. David RD, DeBlieux PMC, Press R. Rational antibiotic treatment of outpatient genitourinary infections in a changing environment. Am J Med. 2005;118 Suppl 7A:7-13.
65. Garau M, Latorre A, Alonso Sanz M. Fosfomicina: un antibiótico infravalorado en infecciones urinarias por Escherichia coli. Enferm Infecc Microbiol Clin. 2001;19:462-6.
66. Oteo J, Lázaro E, De Abajo F, Baquero F, Campos J. Antimicrobial-resistant invasive Escherichia coli, Spain. Emerg Infect Dis. 2005;11:546-53.
67. Gómez-Martínez J, Marco F, Mensa J, Espasa M, Martínez JA, Jiménez de Anta MT. Actividad in vitro de fluoroquinolonas y antibióticos betalactámicos administrados por vía oral frente a aislamientos clínicos de Escherichia coli. Rev Esp Quimioter. 1999;12:54-7.
68. Atienza Morales MP, Castellote Varona FJ, Romero Portilla C. Infección urinaria y sensibilidad antibiótica en el sur de la provincia de Albacete. An Med Interna. 1999;16:236-8.
69. Colomina Avilés J, Fuentes Luri S, Cascales Ramos P, Pascual Pérez R, Cabo Moya C. Infección urinaria y resistencia bacteriana en urocultivos de pacientes ambulatorios. An Med Interna. 2000;17:506-7.
70. Alonso R, Fernández-Aranguiz A, Colom K, Herreras A, Cisterna R. Perfil de aislamientos bacterianos y sensibilidad antimicrobiana. Estudio multicéntrico mediante corte de un día. Rev Esp Quimioter. 2000;13:384-93.
71. Queipo Zaragoza JA, Budia Alba A, Mascaros García E, Gómez-Ferrer Lozano A, Gobernado Serrano M, Jiménez Cruz J. Evolución de la resistencia microbiana a fluorquinolonas en un hospital terciario. Actas Urol Esp. 2000;24:381-7.
72. Daza R, Gutiérrez J, Piédrola G. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections. Int J Antimicrob Agents. 2001;18:211-5.
73. León González E, Calderón Úbeda J, Hernández Martín P, Rodríguez Martínez B, Merino Segovia R, Gil García M. Uso racional del medicamento en el tratamiento de infecciones urinarias en el Área de Talavera de la Reina. Aten Primaria. 2002;29:481-5.
74. Sánchez Merino JM, Guillán Maquieira C, Fuster Foz C, López Medrano R, Jiménez Rodríguez M, García Alonso J. Sensibilidad microbiana de Escherichia coli en bacteriurias en el área sanitaria del Bierzo en el año 2003. Actas Urol Esp. 2004;28:588-93.
75. Junquera S, Loza E, Baquero F. Evolución del patrón de sensibilidad de aislados de Escherichia coli en urocultivos procedentes del medio hospitalario y extrahospitalario. Enferm Infecc Microbiol Clin. 2005;23:197-201.
76. Alós JI, Serrano MG, Gómez-Garcés, JL, Perianes J. Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data. Clin Microbiol Infect. 2005;11: 199-203.
77. Alonso-Sanz M, Abad Bécquer MI. Fenotipos de resistencia en aislamientos urinarios de Escherichia coli en la comunidad: implicaciones terapéuticas. Med Clin (Barc). 2003;120:361-4.
78. Herráiz MA, Hernández A, Asenjo E, Herráiz I. Infección del tracto urinario en la embarazada. Enferm Infecc Microbiol Clin. 2005;23 Supl 4:40-6.
79. Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, et al. Guidelines for treatment of candidiasis. Clin Infect Dis. 2004;38:161-89.
80. Nicolle LE. Urinary tract infection: traditional pharmacologic therapies. Am J Med. 2002;113 Suppl 1A:35-44.
81. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO-SENS Project. J Antimicrobial Chemother. 2003;51:69-76.
82. Ochoa Sangrador C, Eiros Bouza JM, Pérez Mendez C, Inglada Galiana L y Grupo de Estudio de los Tratamientos Antibióticos. Etiología de las infecciones del tracto urinario y sensibilidad de los uropatógenos a los antimicrobianos. Rev Esp Quimioter. 2005;18:124-35.
83. Sábada-Díaz de Rada B, Azanza-Perea JR, García-Quetglas E, Honorato-Pérez J. Fosfomicina trometamol. Dosis múltiples como pauta larga en el tratamiento de las infecciones urinarias bajas. Enferm Infecc Microbiol Clin. 2006;24:546-50.
84. De Cueto M, López L, Hernández JR, Morillo C, Pascual A. In vitro activity of fosfomycin against extended-spectrum-b-lactamase-producing Escherichia coli and Klebsiella pneumoniae: comparison of susceptibility testing procedures. Antimicrob Agents Chemother. 2006;50:368-70.
85. García Rodríguez JA. Bacteriological comparison of cefixime in patients with noncomplicated urinary tract infection in Spain. Preliminary results. Chemotherapy. 1998;44 Suppl 1:28-30.
86. Cabero LI, editor. Sociedad Española de Ginecología y Obstetricia (SEGO). Protocolos asistenciales en obstetricia. Infección urinaria y embarazo. Barcelona: Ediciones Mayo; 2004.
87. Gómez J, Muñoz R, Baños V, Gómez G. Tratamiento de las infecciones urinarias adquiridas en la comunidad: perspectivas actuales y enfoque clínico del paciente. Rev Esp Quimioter. 2005;18:319-27.
88. Moreno-Martínez A, Mensa J, Martínez JA, Marco F, Vila J, Almela M, et al. Cefixima frente a la asociación de amoxicilina con netilmicina en el tratamiento de la pielonefritis aguda no complicada. Med Clin (Barc). 1998;111:521-4.
89. Alhambra A, Cuadros JA, Cacho J, Gómez-Garcés JL, Alós JI. In vitro susceptibility of recent antibiotic-resistant urinary pathogens to ertapenem and 12 other antibiotics. J Antimicrob Chemother. 2004;53:1090-4.
90. Liu H, Mulholland SG. Appropriate antibiotic treatment of genitourinary infections in hospitalized patients. Am J Med. 2005;118 Suppl 7A:14-20.
91. Shen Y, Brown MA. Renal imaging in pyelonephritis. Nephrology. 2004;9:22-5.
92. Stamm WE, Norrby SR. Urinary tract infections: disease panorama and challenges. J Infect Dis. 2001;183 Suppl 1:1-4.
93. Piccoli GB, Consiglio V, Colla L, Mesiano P, Magnazo A, Burdese M, et al. Antibiotic treatment for acute 'uncomplicated' or 'primary' pyelonephritis: a systematic review, «semantic revision». Int J Antimicrob Agents. 2006;28S:S49-S63.
94. Pigrau-Serrallach C. Infecciones urinarias recurrentes. Enferm Infecc Microbiol Clin. 2005;23 Supl 4:28-39.
95. Martínez JA, Mensa J. Infección urinaria asociada a catéteres urinarios en la comunidad. Enferm Infecc Microbiol Clin. 2005;23 Supl 4:57-66.
96. Barrasa Villar JI, Guerrero Navarro JL, Aspiroz Sancho C. Las infecciones urinarias en los pacientes con sonda vesical no permanente (y II). Diagnóstico, tratamiento, prevención y líneas de investigación. Med Clin (Barc). 1996;106:548-54.
97. Cravens DD, Zweig S. Urinary catheter management. Am Fam Physician. 2000;61:369-76.
98. Nicolle LE, the SHEA Long-Term-Care Committee. Urinary tract infections in long-term-care facilities. Infect Control Hosp Epidemiol. 2001;22:167-75.
99. Wong ES, Hooton TM. Guidelines for prevention of catheter associated urinary tract infection. Infect Control. 1982;2:125-30.